AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018
December 11 2017 - 4:01PM
Business Wire
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
surgery, peripheral vascular disease and oncology, today announced
that it will report financial results for the second quarter of
fiscal year 2018 before the market open on Thursday, January 4,
2018. The Company’s management will host a conference call at 8:00
a.m. ET that same day to discuss the results.
To participate in the conference call, dial 877-407-0784
(domestic) or 201-689-8560 (international) and refer to the
passcode 13674426.
This conference call will also be webcast and can be accessed
from the “Investors” section of the Company’s website at
www.angiodynamics.com. The webcast replay of the call will be
available at the same site approximately one hour after the end of
the call.
A recording of the call will also be available from 11:00 a.m.
ET on Thursday, January 4, 2018, until 11:59 p.m. ET on Thursday,
January 11, 2018. To hear this recording, dial 844-512-2921
(domestic) or 412-317-6671 (international) and enter the passcode
13674426.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative,
minimally invasive medical devices used by professional healthcare
providers for vascular access, surgery, peripheral vascular disease
and oncology. AngioDynamics’ diverse product lines include
market-leading ablation systems, fluid management systems, vascular
access products, angiographic products and accessories drainage
products, thrombolytic products and venous products. For more
information, visit www.angiodynamics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171211005978/en/
Investor Contact:AngioDynamics, Inc.Michael Greiner,
518-795-1821Executive Vice President & CFO
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Aug 2024 to Sep 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Sep 2023 to Sep 2024